At BioMarin, we are driven by our purpose: to be the biotech leader that translates the promise of genetic discovery into medicines that make a profound impact on the life…
Read More »BioMarin Pharmaceutical
There are approximately 20,000 genes in the human genome. A mutation, or permanent variation, in just one gene can lead to a genetic condition. Knowing what causes a genetic condition…
Read More »
We are thrilled to present Hemophilia: the Musical! Twenty-five teens from the bleeding disorder community came together in New York City from November 9 to November 12, 2018. They experienced…
Read More »
This short film details the history of phenylketonuria (PKU) and BioMarin’s 15+ year commitment to advancing the standard of care for those living with this rare condition. Watch “The Pursuit…
Read More »
Meet Brett Crawford, BioMarin’s Head of the Musculoskeletal Therapeutic Area in BioMarin Research. Source BioMarin Pharmaceutical YouTube
Read More »
When it comes to commitment to patients, BioMarin has a lock on it. Each Rare Disease Day, we recognize people impacted by a rare genetic disease, as well as advocates…
Read More »
At BioMarin, the Trees of Life Love Lock Ceremony has become a traditional recognition of Rare Disease Day. Each lock on the Trees of Life sculpture represents BioMarin’s unwavering commitment…
Read More »
What happens when you bring 25 teens from the bleeding disorders community together in New York City to make a musical? Rehearsals, singing on the subway, meeting Broadway stars, and…
Read More »
Achondroplasia, the most common cause of short stature, or dwarfism, affects nearly all of the bones in the body. As a result, on average people with achondroplasia are around 25%…
Read More »
BioMarin started her journey at BioMarin in the Bioanalytical Science department. Today, she has built a team and leads Hematology Development. — BioMarin is a global biotechnology company focused on…
Read More »